Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura.Published in:American Journal of Health-System Pharmacy, 2009, v. 66, n. S2, p. S4, doi. 10.2146/ajhp080490By:Pruemer, JanePublication type:Article
Treatment options for chronic immune thrombocytopenic purpura.Published in:American Journal of Health-System Pharmacy, 2009, v. 66, n. S2, p. S3, doi. 10.2146/ajhp080505By:Pruemer, JanePublication type:Article
New options after first-line therapy for chronic immune thrombocytopenic purpura.Published in:American Journal of Health-System Pharmacy, 2009, v. 66, n. S2, p. S11, doi. 10.2146/ajhp080493By:Burzynski, JuliannaPublication type:Article
Treatment Options for Chronic Immune Thrombocytopenic Purpura.Published in:American Journal of Health-System Pharmacy, 2009, v. 66, n. S2, p. S22Publication type:Article